CureMatch Articles & News
CureMatch’s Tsigelny is a featured author in Briefings in Bioinformatics journal with a review on artificial intelligence’s usefulness in drug combination therapy recommendations. SAN DIEGO, CA – February 12, 2018: Igor F. Tsigelny, Ph.D., Co-founder and Chief Science Officer at CureMatch®, is the author of “Artificial intelligence in drug combination therapy” in Briefings in Bioinformatics […]
Molecular study offers insights for possible cure of treatment resistance and new drug possibilities based upon better understanding of the GRP78-Cripto Protein. CureMatch’s Tsigelny published in current Protein Science Journal article. SAN DIEGO, CA – January 31, 2018: Igor F. Tsigelny, Ph.D., Co-founder and Chief Science Officer at CureMatch®, is a senior author of “Cripto […]
CureMatch® CTO is co-author in Cancer Discovery Journal article showing computational modeling of drug resistance caused by gene mutations advances personalized cancer medicine. SAN DIEGO, CA – January 25, 2018: Igor F. Tsigelny, Ph.D., Co-founder and Chief Technology Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape […]
CureMatch® to exhibit and share advances in precision medicine at The Precision Medicine World Conference, PMWC 2018; to highlight the CureMatch PreciGENE™ report which is used to guide oncologists in the selection of a personalized cancer treatment plan, using supercomputing and the latest discoveries in genomics and proteomics. SAN DIEGO, CA – January 18, 2018 […]
Oncologists Can Now Specify Cancer Treatment Options to Score and Rank with CureMatch using the new PreciGENE™ Personalized Combination Therapy® Reports to be introduced at Biotech Showcase™Annual Conference. SAN DIEGO, CA – January 08, 2017 – CureMatch® will present the new release of PreciGENE™ Personalized Combination Therapy® at Biotech Showcase™ 2018, to be held January 8–10 […]